Skip to main content
. 2007 Nov;60(11):1226–1231. doi: 10.1136/jcp.2007.046441

Table 3 Summary of clear cell sarcoma of the kidney (CCSK) cases.

Case no. Diagnosis Treatment Age (months) Stage KIT IHC KIT CISH KIT mutation
RMH0471 CCSK Preoperative chemotherapy NA NA Strong, 10–33% NA Negative
RMH0751 CCSK Immediate nephrectomy 19 2 Strong, 10–33% Not amplified Negative
RMH0753 CCSK Immediate nephrectomy 20 2 Strong, >70% Not amplified Negative
RMH1226 CCSK Preoperative chemotherapy 22 3 Negative Not amplified NA
RMH1278 CCSK Preoperative chemotherapy 28 3 Negative Not amplified NA
RMH1286 CCSK Preoperative chemotherapy 12 3 Negative Not amplified NA
RMH1330 CCSK Preoperative chemotherapy 28 3 Negative NA NA
RMH1518 CCSK Preoperative chemotherapy 7 3 Negative Not amplified NA
RMH1826 CCSK Preoperative chemotherapy 24 2 Negative Not amplified NA
RMH1880 CCSK Immediate nephrectomy NA NA Negative Not amplified NA
RMH1910 CCSK Immediate nephrectomy 15 NA Weak, 10–33% Not amplified NA
RMH1931 CCSK Immediate nephrectomy 14 NA Weak, 33–66% Not amplified NA

NA, not applicable.

No gene amplification or activating mutations were observed.